Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas: Evolution in the course of infection and after treatment

Veterinary Parasitology

Volumn 96, Issue 4, 2001, Pages 265-276

  Solano Gallego, Laia ^a   Riera, Cristina ^b   Roura, Xavier ^a   Iniesta, Laura ^b   Gallego, Montserrat ^b   Valladares, Josep Enric ^a   Fisa, Roser ^b   Castillejo, Soledad ^b   Alberola, Jordi ^a   Ferrer, Lluis ^a   Arboix, Margarita ^a   Portús, Montserrat ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dog; Immunoglobulins; Leishmania infantum; Response to treatment

Indexed keywords

ALLOPURINOL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOG; ENDEMIC DISEASE; IMMUNOGLOBULIN BLOOD LEVEL; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PROTEIN EXPRESSION; SPAIN; TREATMENT OUTCOME;

ALLOPURINOL; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIPROTOZOAL AGENTS; DOG DISEASES; DOGS; ENDEMIC DISEASES; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LONGITUDINAL STUDIES; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 0035912256     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(00)00446-5     Document Type: Article

References (23)

1. An experimental model for canine visceral leishmaniasis
2. Epidemiology of canine leishmaniasis in the Madrid region
3. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy
4. Canine leishmaniasis in the Mediterranean area and its implications for human leishmaniasis
5. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs
6. The immunology of canine leishmaniosis: Strong evidence for a developing disease spectrum from asymptomatic dogs
7. Antibody response in dogs experimentally infected with Leishmania infantum: Infection course antigen markers
8. Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum
9. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites
10. Serological diagnosis and treatment of canine leishmaniasis
11. Epidemiology of canine leishmaniosis in Catalonia (Spain). The example of the Priorat focus
12. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection
13. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis
14. Ecologie des leishmanioses dans le sud de la France. 10 Les formes évolutives de la leishmaniose viscérale canine. Elaboration d'une typologie bioclinique à finalité épidémiologique
15. + cell development
16. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment
17. + antigen-specific T cells
18. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis
19. Analysis of the humoral immune response against totals and recombinant antigens of Leishmania infantum: Correlation with disease progression in canine experimental leishmaniasis
20. Cellular and humoral immune response in dogs experimentally and naturally infected with Leishmania infantum
21. T-cell cytokine responses in leishmaniasis
22. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate
23. The ibizian hound presents a predominantly cellular immune response against natural Leishmania infection